Saving changes...

Done

Error

Diabetes Update 2014

Diabetes Update 2014

Diabetes Update 2014

Susan Cornell, BS, PharmD, CDE, FAPHA, FAADE
Susan Cornell, BS, PharmD, CDE, FAPHA, FAADE
on behalf of University of Texas at Austin College of Pharmacy

$10.00 $ 10.00 $ 10.00

$10.00 $ 10.00 $ 10.00

$ 10.00 $ 10.00 $ 10.00
$ 10.00 $ 10.00 $ 10.00
Normal Price: $10.00 $10.00

Review:

Launch date: 09 Mar 2017
Expiry Date:

Last updated: 13 Mar 2017

Reference: 171007

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

Diabetes is one of the most common chronic diseases in the U.S.; it is estimated that nearly 26 million people are affected – or about 8.3% of the population. The diabetes epidemic does not seem to be stopping, but instead is accelerating as people continue to live longer and more people, including children, adolescents, and young adults, are diagnosed with this disease. Projections suggest that the prevalence of diabetes (diagnosed and undiagnosed) will increase from the current level of 1 in 9 adults to as many as 1 in 3 adults by the year 2050. The impact of diabetes on health is significant. Complications arising from uncontrolled diabetes include macrovascular disease (eg, atherosclerosis leading to heart attacks and strokes) as well as microvascular disease (eg, retinopathy, kidney damage, and neuropathy). These complications now account for nearly 14% of all U.S. healthcare expenditures. The estimated total cost of diagnosed cases of diabetes was $245 billion in 2012, up from $174 billion in 2007. The largest component of this cost (43%) was inpatient medical care. Other direct costs included medications, physician office visits, and nursing/residential facility care. The average person with diabetes spends $13,700 per year on medical expenses; $7,900 is directly attributable to diabetes. In addition, immense indirect costs result from lost productivity, which can also have a psychosocial impact (Table 1). Management of diabetes can be challenging. Delays in diagnosis and suboptimal treatment after diagnosis may contribute to poor health and increased healthcare costs. Educating patients and caregivers about glucose control, blood pressure control and lipid management, along with preventive care for diabetes-related neuropathy affecting the eyes, ears, feet, kidneys, bladder, nerves and heart, can help reduce complications and related hospitalizations. Healthcare providers must stay current with evidence-based recommendations for drug therapy and other medical treatments in an effort to provide optimal, individualized, continuous care for patients with diabetes. This issue focuses on recent changes to the American Diabetes Association (ADA) Standards of Medical Care and new trends in diabetes management. Newly approved medications (canagliflozin [ Invokana ™], dapagliflozin [ Farxiga ™] will be covered in the July/August issue. Format This CE activity is a monograph (PDF file).

Objectives

Objectives
Describe the methods used for screening and diagnosing diabetes, including type 1 and gestational diabetes. State the current ADA recommendations for frequency of follow-up after diagnosis. List 3 non-insulin diabetes drugs that may be used (with insulin) in type 1 diabetes. Explain the rationale(s) for their use. Discuss the use of metformin in patients with chronic kidney disease. Explain the problem of clinical inertia in diabetes management; list 1 recommended solution. Review the evidence linking statins and certain antihypertensive drugs to an increased risk of diabetes. Outline key ADA recommendations for inpatient care of people with diabetes, including discharge planning and transitions of care
Susan Cornell, BS, PharmD, CDE, FAPHA, FAADE

Author Information Play Video Bio

Susan Cornell, BS, PharmD, CDE, FAPHA, FAADE
on behalf of University of Texas at Austin College of Pharmacy

Susan Cornell, BS, PharmD, CDE, FAPHA, FAADE, Associate Professor of Pharmacy Practice and Assistant Director, Experiential Education, Midwestern University Chicago; Clinical Pharmacist and Certified Diabetes Educator, DuPage Community Clinic, Il

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.50 Hours -
    Exam Pass Rate: 75
    -
    Reference: 0428-0000-14-008-H01-P

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error